Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines ...

Waiver confirms that paediatric studies of certepetide in pancreatic cancer are not needed

Related Keywords

Elizabeth Coleman ,John Menditto ,European Medicines Agency ,Paediatric Committee ,Nasdaq ,Lisata Therapeutics Inc ,European Union ,Exchange Commission ,Corporate Communications ,Paediatric Investigation Plan ,Executive Vice President ,Chief Medical Officer ,Paediatric Regulation ,Fast Track ,Orphan Drug Designation ,Rare Pediatric Disease Designation ,Cendr Platform ,Private Securities Litigation Reform Act ,Nasdaq Capital Market ,Annual Report ,Investor Relations ,